San Francisco, CA -- (SBWIRE) -- 08/16/2019 -- Global Metagenomics Market: Overview
Metagenomics has emerged as a new paradigm in microbiology in the genomic analysis of genetic material recovered from microbial communities. The approach has recently generated vast interest among microbiologists across the world in supporting the underlying research techniques for studying the vast range of microbes present in environment. The evolution of the metagenomics market is reinforced by constant efforts by researchers to leverage its potential in exploring novel physiological, metabolic, and genetic features, especially from genomic analysis of uncultured bacteria. The market is still in nascent stage and constant advances in bioinformatics methods are opening exciting avenues in sequencing-based metagenomics. The growing use of high-throughput sequencing of microbiomes through metagenomics is expected to expand the potential of the market. The advent of sophisticated bioinformatic tools and workflows pertaining to metaproteomics, metabolomics, and metatranscriptomics has changed the landscape of metagenomics market.
Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=4005
Global Metagenomics Market: Key Trends
The rising application of metagenomics is driven by the need for better understanding of the microbial diversity and ecology of an environment. The trend is gathering traction among life science companies for the discovery of novel genes and molecules from noncultivated and uncharacterized microorganisms. Rapid advancements in genomic technologies are accentuating the demand for metagenomics in the various life science industries world over. The metagenomics market is also witnessing attractive strides by the development of protocols for the genomic analysis of microbial consortia within the host cell. The launch of new sequencing technologies by bioinformatics companies and the gradual decline in their cost are factors expected to boost the market.
Global Metagenomics Market: Potential
Efforts for analyzing the genomic sequences of environmental bacteria has been receiving a robust fillip from the launch of a few cutting-edge workflow tools for sequencing over the past few years. Some of the notable ones are shotgun metagenomics, De novo assembly, and 16S rRNA sequencing. The use of these methodologies has helped fill the gap in human microbiome research and development. The potential, however, has largely been constrained by cost concerns, and several genomics companies are working in this direction. CoreBiome, a U.S.-based genomics company, has in June 2018 announced an affordable and advanced shotgun metagenomic and strain sequencing tests that help in gene profiling of human microbiome. The platform can be combined with its sequencing assay for making the analysis of plant tissues and biopsies. Such products enable researchers in in-depth characterization of microbial isolate libraries.
Strategic partnerships between metagenomics companies and healthcare providers helps in better utilization of clinical metagenomic testing platforms. A recent such collaboration is by a metagenomics technology company, IDbyDNA. The company announced in September 2018 that it has entered into a licensing agreement with Fleury Group, a prominent health organizations in Brazil. The later company can now leverage the potential of Explify platform South America to expand its pathogen detection portfolio for serious infection cases. Such developments help in expanding the sustainability of the healthcare system.
Request TOC for Facts & Tables @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=4005
Global Metagenomics Market: Regional Outlook
The report offers a detailed assessment of the regional growth dynamics and the prevailing opportunities in key regions. On the regional front, developed regions are likely to exhibit substantial potential in the expansion of the global metagenomics market over the assessment period of 2018–2028. Regions, such as North America, are witnessing the launch of several advanced metagenomics platforms and workflows. The product development initiatives in these regions are fueled by the presence of numerous biotechnology companies. Developing regions are also expected to witness promising growth in the coming years.
Global Metagenomics Market: Competitive Outlook
The study takes a closer look at the current competitive landscape in various regions and evaluates the impact of recent product launches on the growth trajectories of the metagenomics market. It offers insights into their revenue and share size and the strategies adopted by key players to retain stronghold in the market. Some of the prominent players operating in the metagenomics market are ELITechGroup, Qiagen, Danaher Corporation, TAKARA BIO INC., Thermo Fisher Scientific, Novogene Corporation, and Promega Corporation.